Literature DB >> 28502480

Stenotrophomonas maltophilia in a university hospital of traditional Chinese medicine: molecular epidemiology and antimicrobial resistance.

S Zhao1, L Yang2, H Liu2, F Gao2.   

Abstract

Stenotrophomona maltophilia has emerged as an important opportunistic pathogen that is highly antibiotic resistant. Analysis of antibiotic susceptibilities, drug-resistant gene profiles and molecular typing of S. maltophilia was undertaken in a university hospital of traditional Chinese medicine in East China. Resistance to sulphamethoxazole (SXT) was found to be an indicator of multi-drug resistance. SXT resistance was mediated by sul and dfrA genes in integrons, especially class 1. Some evidence of clonal dissemination was found, indicating the occurrence of cross-transmission of antibiotic-resistant strains within the hospital. This underscores the need for effective control and prevention measures in hospitals.
Copyright © 2017 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibiotic resistance; Molecular epidemiology; Stenotrophomonas maltophilia

Mesh:

Year:  2017        PMID: 28502480     DOI: 10.1016/j.jhin.2017.04.001

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  3 in total

1.  Oropharyngeal and Sputum Microbiomes Are Similar Following Exacerbation of Chronic Obstructive Pulmonary Disease.

Authors:  Hai-Yue Liu; Shi-Yu Zhang; Wan-Ying Yang; Xiao-Fang Su; Yan He; Hong-Wei Zhou; Jin Su
Journal:  Front Microbiol       Date:  2017-06-22       Impact factor: 5.640

2.  Advances in the Microbiology of Stenotrophomonas maltophilia.

Authors:  Joanna S Brooke
Journal:  Clin Microbiol Rev       Date:  2021-05-26       Impact factor: 50.129

3.  Clinical and Molecular Epidemiology of Stenotrophomonas maltophilia in Pediatric Patients From a Chinese Teaching Hospital.

Authors:  Zhongliang Duan; Juanxiu Qin; Cui Li; Chunmei Ying
Journal:  Front Cell Infect Microbiol       Date:  2020-08-11       Impact factor: 5.293

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.